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ABSTRACT 
Background: Evidence suggests that inpatient palliative care consultation (IPC) services 
improve the likelihood of fewer hospital readmissions for those with Alzheimer's disease and 
dementia. 
Objective: This study examines the difference in readmission rates for Alzheimer's patients with 
and without inpatient palliative care consultations. 
Design: This is a retrospective data analysis using an inception cohort derived from HCUP 
archival data from the state of Florida for the year 2012: Only acute care patients with a 
diagnosis of Alzheimer's disease or dementia who were hospitalized for either the dementia 
condition or because of acute urinary tract infection (UTI), pneumonia, congestive heart failure 
(CHF) were included in this study. 
Methods: Analyses were performed using SAS v 9.3. Mean values and percentages were used 
for description and population. Differences between groups were tested using chi-square and t-
test or non-parametric statistics as appropriate. Multivariable modeling was performed using 
logistic regression. 
Results: Of the 7308 patients in our study, 1266 (17.3%) were readmitted within 30 days. 
However, only 1.9% of the readmitted patients recei~ed and inpatient palliative care consultation 
during the index admission. 
Conclusions: Inpatient palliative care consultations do positively affect the hospital 




We are an aging nation. The number of Baby Boomers, those born between 1946 and 
1964, are now utilizing our health care system more than ever. Many are doing so with a chronic 
illness such as dementia, or more specifically, Alzheimer's disease. The United States spends 
more per capita than any country on healthcare, yet the quality of care is often fragmented with 
very little communication and tremendous strains on family caregivers. To combat costs and 
improve patient satisfaction, hospitals have been implementing palliative care programs with 
specialists who can assist patients to navigate their disease trajectory. Unfortunately those who 
are functionally and mentally impaired must circumnavigate among care providers who have 
vastly different objectives, workforce abilities, and quality and payment incentive models. 
Palliative Care has been offered in the United States since the l 970's. Hospice care, care 
for those who have a terminal illness, has been reimbursed by Medicare since 1982. The growth 
has expanded from one hospice in 1974 to over 5000 today (Lutz, 2011). These services, 
although performed in many different healthcare arenas, assist in helping the patient navigate 
their disease process in a pain free manner while managing symptoms of their disease through an 
interdisciplinary approach (Morrison & Meier, 2011). Palliative care programs moved into 
Academic Medical Centers first and have progressed to smaller, more rural hospitals. The 
concept has achieved recognition as a best practice in care management. As with the 
development of any new program or service, the dissemination of data, implementation of 
evidenced based care, and adoption of protocols will happen at different rates depending on the 
champion leadership that it is given. 
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Focus on Hospital Readmission Rates 
The Patient Protection and Affordable Care Act designates reduction of avoidable re-
hospitalizations as a target for health care cost savings and authorizes lower payments to 
hospitals with high risk-standardized rates of readmission. Reducing re-admission rates may be 
facilitated by a provision of the legislation (section 3026 of HR 3590) that provides $500 million 
to the Centers for Medicare & Medicaid Services to fund the Community-based Care Transitions 
Program. The Medicare Payment Advisory Commission has estimated that three quarters of such 
re-hospitalizations may be avoidable and annually account for billions in excess health care costs 
(Hansen, Young, Hinami, Leung, & Williams, 2011). Medicare is thus looking at readmission 
rates now as a quality measure, openly publishing the rates of readmission among patients with 
acute myocardial infarction, congestive heart failure, and pneumonia, comparing hospitals across 
the nation (Cakir & Gammon, 2010). While this is the start, the medical community expects the 
number of diagnosis reported and monitored will continue to grow as it did in 2014 with the 
addition of readmissions for hip and knee replacements and those suffering from chronic 
bronchitis (Rau 2014). 
The National Pilot Program on Payment Bundling (Section 3023), established in January 
2013, is a retrospective payment for hospitals for episodic-based care. More specifically the 
episode of care to be covered under the proposed models will begin days before the hospital 
admission and extend through thirty or ninety days after discharge. Participating providers may 
receive bundled payments for inpatient, physician, outpatient, and post-acute care services. A 
bundled payment, or set dollar amount, is to be paid to an integrated delivery system for the total 
episode of care with no additional payment for specific services such as physician visits or post-
acute care. Bundles have the potential to reduce costs, have providers deliver care in the lowest-
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cost setting to maximize their operating margin, and potentially avoid expensive post-acute stays. 
While this method will put a greater focus on the transition process from the hospital to home, it 
does not pay for any long-term care nursing home services (Naylor et al., 2012). 
There are several other methods proposed to minimize readmissions. They focus on 
developing better processes for care, implementing lean methodologies, improve discharge 
planning, and develop partnerships along the continuum of care. While partnerships, such as 
Accountable Care Organizations (ACOs}, are not showing reductions across the board, they are 
incentivizing providers to not only tweak how care is delivered, instead they are redesigning it all 
together (Caramanica & Delk, 2014). This redesigning of health care processes will hopefully 
advance how palliative care programs are implemented in the acute care setting. 
Palliative Care Programs in the Hospital 
Historically, palliative care was only offered to patients with a cancer diagnosis. 
However, it has expanded to all patients with a chronic or incurable diagnosis (Bush & Shahwan-
Akl, 2013) including to those individuals who have been diagnosed with Alzheimer's disease or 
other dementias. (See Figure 1). An inpatient palliative care consultation (IPC), like other 
specialist consultation, is typically initiated at the request of the treating physician. IPC teams 
communicate their recommendations back to the referring physician for implementation. 
Additionally, palliative teams focus on clarifying diagnoses and treatment options, helping 
patients and family members identify goals of care, and helping them select, in conjunction with 
their treating physicians, the treatments and hospital discharge options that meet those goals 
(Morrison et al., 2011 ). 
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Figure 1. Prevalence of US Hospital Palliative Care Teams 
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IPCs for Alzheimer's disease and related Dementias 
Alzheimer's disease is recognized as the leading cause of dementia, and is a chronic 
degenerative progressive disease. Along with the other dementias, disease progression in the 
moderate-to-severe stages share a common clinical pathway, being that ultimately admission to a 
specialty dementia unit, nursing home, or an acute general hospital may happen for a multitude 
of reasons (Coleman, 2012). Earlier recognition of dementia patients and subsequent IPCs are 
needed to better manage predictable complications and relieve overall suffering. In particular, 
IPC services can help diagnose dementia, create an opportunity to conduct a well-informed goals 
of care discussions, provide guidance in understanding prognosis, manage patients' distressful 
symptoms, provide emotional, spiritual, and social support for the patient and caregivers, and 
explore the services available at home to improve access to care upon hospital discharge (Ouchi 
et al., 2014). 
Current Political Environment 
Current Medicare regulations have an adverse impact on hospice access for individuals 
with Alzheimer's because of the requirement of a six-month survival prognosis certified by two 
physicians. The most common cause of mortality in advanced AD are concurrent infections, 
which occur and recover at unpredictable rates. Therefore, the determination of a six-month 
survival prognosis cannot be made with a high degree of certainty. The complexity of managing 
comorbid conditions and the transition to appropriate end-of-life care creates challenging and 
costly issues of care coordination between health care providers and community service 
providers. At the same time, the current inability to cure Alzheimer's disease and related 
dementias gives scientists a strong desire to discover early interventions to keep people from 
developing dementia and beginning what is now an inexorable decline (Bynum, 2014). 
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In its report to Congress on March 25, 2009, the Alzheimer's Study Group, a task force 
co-chaired by former House Speaker Rep. Newt Gingrich (R-GA) and Sen. Bob Kerrey (D-NE) 
along with leading experts in federal health policy, presented recommendations to accelerate and 
focus national efforts to address the growing Alzheimer's crisis. These recommendations spurred 
the creation of the National Alzheimer's Project Act (NAPA}, which was signed into law by 
President Barack Obama on January 4, 2011, after unanimous passage in the final days of the 
11 lth Congress. Fundamentally, then, the Alzheimer's Study Group recognized that Alzheimer's 
is currently placing a staggering burden upon society as a result of the costs of caring and 
supporting those with Alzheimer's and their caregivers. This burden will increase sharply in the 
coming decades, and the only feasible means of altering this trajectory is through biomedical 
research that yields effective interventions (Egge, 2014). 
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Two significant activities were undertaken to assess the scale and scope required to 
successfully reach the 2025 goal of"Prevent and effectively treat Alzheimer's disease by 2025." 
The first was conducted by a task force of leading researchers in the field, the Alzheimer's 
Association Expert Advisory Work-group on NAP A. In an effort to inform those implementing 
NAP A, this workgroup assessed requirements in scientific and technological areas, infrastructure 
and research resource spheres, and administrative and organizational domains. Taken together, 
the workgroup's professional judgment budget estimated that a successful effort would require at 
least $2 billion per year over ten years (Egge, 2014). 
The second effort was the Alzheimer's Disease Research Summit 2012: Path to 
Treatment and Prevention, under the direction of the NIH and the NIA. The summit convened 
more than 500 participants; although participants did not attempt to develop budgetary estimates, 
their work did also culminate in an assessment of research requirements and a corresponding 
series of recommendations (Egge, 2014). 
Problem Statement 
It is unclear if inpatient palliative care consultations make a difference for those with 
Alzheimer's disease. We do know individuals with Alzheimer's and other dementias have more 
than three times as many hospital stays per year as other people in the same age brackets. In 
2008, there were 780 hospital stays per 1000 Medicare beneficiaries age 65 and older with AD 
and other dementias compared with 234 hospital stays per 1000 Medicare beneficiaries age 65 
and older without these conditions. The most common reasons for hospitalization of people with 
AD include syncope, fall and trauma, ischemic heart disease, and gastrointestinal disease (Thies 
& Bleiler, 2013). 
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Based upon these considerations, Daiello, Gardner, Epstein-Lubow, Butterfield, and 
Gravenstein (2014) hypothesized that older adults with a diagnosis of dementia would be more 
likely to be quickly re-hospitalized following an acute care stay, compared to their peers without 
dementia. Grim, McElwain, Hartmann, Hudak, and Young (2010) stated the top reasons for re-
admission of those receiving palliative care were disease progression and the development of co-
morbidities. This is not surprising for those who suffer :from dementia as the number of comorbid 
conditions is generally significant. 
Hypothesis 
Hypothesis 1: Inpatient Palliative Consultations will reduce hospital readmissions 
for patients who are suffering from Alzheimer's disease and dementia. This study will show 
the benefit of utilizing IPCs in regards to costs, lengths of stay for initial admissions, and 
reductions in re-admissions. 
Hypothesis 2: This study will show the effect of the inpatient palliative care 
consultations has on reducing re-hospitalization is reduced as the number of comorbidities 
increases. 
Target Audience for the Study 
This research can have implications for several groups of people. Hospitals, palliative 
care practitioners, and advocates for those who have Alzheimer's disease are greatly affected by 
this research. Although the number of readmissions may be declining over the past two years for 
Medicare hospital readmissions, the fines are increasing at an alarming rate. In fact, over 2,610 
hospitals were fined in 2014 (Rau, 2014). With reimbursement methodologies increasingly 
becoming more of a focus, hospital administration should review care delivery models and the 
welfare of their patient after discharge. Palliative care professionals need to be aware of how 
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hospital readmission rates affect them. As hospital administrators are looking at ways to reduce 
costs, they will look to the palliative care team to initiate contact to those patients who seem to 
be admitted frequently, often initiating care in the emergency room. Partnerships will need to be 
formed between health systems and hospice organizations to ensure proper diagnosis, prognosis, 
and follow-up care can be delivered. Finally, those that advocate for individuals with 
Alzheimer's disease and related dementia's need to understand the changing face of the 
healthcare environment. They need to understand the care delivery system is changing and tools 
and resources will have to be obtained in order to adequately care for those with this disease. 
Without the proper education on how to effectively cope with this disease, the revolving door of 
the hospital will continue to turn. 
Definition of Terms 
Several terms will be used throughout this dissertation. Often, they are used 
interchangeably, when, in fact, they have very distinct meanings. This section will educate the 
reader on the exact meaning of each of definition. 
Dementia - Dementia does not describe a specific disease. Instead it explains an array of 
symptoms associated with a decline in memory or other thinking skills severe enough to 
diminish a person's ability to perform daily tasks. This term is often misused as senility, which 
describes the normal progress of the mind aging. 
Alzheimer's disease (AD) - Alzheimer's disease is the most common form of dementia where 
nerve cells in the brain deteriorate and die. Alzheimer's affects different people in different 
ways. Symptoms include memory loss that disrupts daily life, difficulty in completing familiar 
tasks, difficulty in ascertaining visual images, the inability to retrace steps, withdrawal from 
work or social activities, among many others. Those with advanced dementia may need help with 
activities of daily living, fail to recognize loved ones, and often become vulnerable to infections 
(Alzheimer's, 2010). 
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Hospice - A model of quality care exhibiting compassion for those who have a life-limiting 
illness. Care is provided in an interdisciplinary approach addressing emotional, spiritual, and 
physical needs of the patients and their family. It focuses on caring for the patient in any location 
they reside and does not discriminate based on age, religion, race, or illness. It is reimbursed by 
Medicare, Medicaid, most private insurance plans, and other managed care organizations 
(NHPCO, n.d. ). 
Palliative Care (PC)-The World Health Organization states palliative care is an approach that 
improves the quality of life of patients and their families facing the problems associated with 
life-threatening illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other problems, physical, 
psychosocial and spiritual (Lutz, 2011 ). 
Inpatient Palliative Care Consultation (/PC) - Services provided by an interdisciplinary team to 
address pain and symptom control, lack of communication with physician's and staff, and 
unwanted life-sustaining treatments by not only addressing the patient's physical needs but also 
their spiritual and psychosocial needs by aligning treatment choices with patients values and 
goals (Armstrong, Jenigiri, Hutson, Wachs, & Lambe, 2013). 
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Figure 2. AU hospice care is palliative care, but not all palliative care is hospice care. 
Source: (NHPCO www.nhpco.org) 
The Difference Between Hospice and Palliative Care 
Palliative care in the USA has evolved from a singular focus on persons at the end-of-life, 
for which care was solely directed on comfort, to a more broad-based interdisciplinary specialty 
that addresses the needs of all seriously ill persons and their families. See Figure 3. US palliative 
care is now conceptualized as patient-centered and family-centered care that optimizes quality of 
life by anticipating, preventing, and treating suffering. A Department of Health, task force in 
1978 reported that "the hospice movement as a concept for the care of the terminally ill and their 
families is a viable concept and one which holds out a means of providing a more humane care 
for Americans dying of terminal illness while possibly reducing costs" (Morrison, 2013). 
Eligibility for hospice under Medicare requires that two physicians certify that the patient 
will die within 6 months 'if the disease runs its normal course' and that the patient agrees to 
forego regular insurance coverage for life-prolonging and curative treatments. In 2011, there 
were approximately 2,513,000 deaths in the USA with 1,059,000 (46%) of those deaths 
occurring under the care of one of over 5000 hospices (Morrison, 2013). Both hospice and non-
hospice professionals have participated in extending the hospice methodology through 
development of palliative care services. Palliative care may be delivered concurrently with all 
appropriate curative and life- prolonging interventions (Meier, 2006). 
Figure 3. Conceptual Shift In Palliative Care Models 















A search was conducted utilizing the Ovid (Medline) database using English language 
papers published in peer-reviewed journals from 2000-2015. Inclusive, broad terms such as 
Alzheimer's, dementia, hospital readmissions, palliative care, and inpatient palliative care 
consultations were applied. Resources were also used from organizations such as the 
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Alzheimer's Association, National Hospice and Palliative Care Organization, and the Center to 
Advance Palliative Care. In addition, experts in the fields of palliative care, Alzheimer's disease, 
and research methodologies were consulted. Reference lists of all included studies were 
reviewed for additional or subsequent publications. 
The goal of the literature review is to gain a broader understanding of previously 
published studies on hospital readmissions for those with Alzheimer's disease and how inpatient 
palliative care consultations may or may not assist with subsequent admissions. Through this 
literature review, the reader should gain a broader understanding of the importance that should 
be placed on inpatient palliative care consultations for those who suffer with Alzheimer's 
disease. 
12 
Focus on Hospital Readmissions 
Readmissions are common in the hospital setting, especially for those that are elderly, 
frail, and have many co-morbid conditions. To this fact, add the increasing cost of healthcare 
services and the need for policy change. Cakir and Gammon (2010) estimate the number of 
individuals that are readmitted to the hospital within 30 days falls between 14.1%and23.2%, but 
when you assess for factors like socioeconomic issues, those numbers rise dramatically. In 2013, 
nearly 18% of Medicare patients who had been hospitalized were readmitted within 30 days. 
This cost Medicare $26 billion dollars. Of that, $17 billion were from potentially avoidable 
readmissions (Rau, 2014). 
The Hospital Readmission Reduction Program (HRRP), an effort on behalf of the Centers 
for Medicare and Medicaid Services (CMS) began in October 2012. Its aim was to reduce 
admissions for patients diagnosed with myocardial infarction, pneumonia, and congestive heart 
failure (Joynt & Jha, 2013). CMS added three additional diagnoses in 2015. Those readmitted 
with exacerbation of chronic obstructive pulmonary disease, elective total hip arthroplasty, and 
elective total knee arthroplasty will now be included in the HRRP program (Centers for & 
Medicaid Services, 2014). 
While there is evidence that a change in hospital processes need to occur to reduce cost, 
many argue on the penalties assessed. Penalties have increased 1 % since the inception of the 
HRRP and will be increased to 3% in 2015. Gu et al. (2014) also make two controversial points 
about the program. First, should the hospital be the place to receive the penalty when the events 
that led up to the readmission take place outside of the hospital. Second, and more complicated, 
has to deal with the individuals who are at risk: those who are the sickest and those who are 
socioeconomically disadvantaged. With the program going into its third year, we are seeing that 
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safety net hospitals and academic medical centers are a large portion of those being penalized. 
Those two entities are the ones who see our sickest patients and those who suffer from economic 
disparities. In 2006 Medicare spending for patients who had mental deficits in addition to 
physical chronic conditions was twice as much as those who did not have any mental deficits 
(Naylor et al., 2012). 
In order for newer models of care to be implemented, improved relationships need to 
occur between providers, patients, payers, regulators, and community service organizations. 
Hospitals and healthcare organizations often work in silos. In order for integration to occur, 
greater collaboration within these groups will need to come together to create a shared vision and 
a mutual accountability for the defined patient population. Well-Star Health System, an 
integrated delivery system in the southeast, includes 5 hospitals, home care, long-term acute 
care, long-term nursing care, residential, an in-patient hospice, and a large physician group. This 
group was an early participant in the Medicare Shared Savings Plan serving 38,000 beneficiaries. 
They have learned the best way to take care of their patients is outside the four walls of the 
hospital. They effectively manage chronic conditions such as Alzheimer's, congestive heart 
failure, and COPD in the outpatient setting. In the first year, Wellstar saw a 15.5% reduction in 
hospital readmissions and a 4.8% reduction in emergency department utilization (Caramanica & 
Delk, 2014). 
Understanding Alzheimer's 
Alzheimer's is a form of dementia. To meet DSM-N criteria for dementia, the following 
are necessary. Symptoms must include decline in memory as well as in at least one of the 
following cognitive capabilities: (I) ability to speak coherently or understand written language, 
(2) ability to recognize or identify objects, assuming intact sensory function, (3) ability to 
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perform motor activities, assuming intact motor abilities and sensory function and 
comprehension of the required task, ( 4) ability to think abstractly, make sound judgments and 
plan and carry out certain tasks. Those with Alzheimer's often demonstrate memory loss that 
disrupts daily life, challenges in planning or solving problems, difficulty completing familiar 
tasks at home, at work, or at leisure, confusion with time or place, trouble understanding visual 
images and spatial relationships, new problems with words in speaking or writing, misplacing 
things and losing the ability to retrace steps, decreased or poor judgment, and changes in mood 
or personality (Thies & Bleiler, 2013). As one can imagine, having a loved one who was once 
independent with the tasks of daily life now depending on a family member with the help of a 
healthcare professional can be burdensome for all, especially in regards to cost. 
Alzheimer's Disease by the Numbers 
An estimated 5.2 million Americans of all ages have AD in 2013. This includes an 
estimated 5 million people age 65 and older and approximately 200,000 individuals younger than 
age 65 who have early onset AD. One in nine people age 65 and older (11 %) has AD. About one 
third of people age 85 and older (32%) have Alzheimer's. Of those with AD, an estimated 4% 
are younger than age 65, 13% are 65 to 74 years old, 44% are 75 to 84 years old, and 38% are 85 
years or older. Of the 5 million people age 65 years and older with AD in the United States, 3.2 
million are women and 1.8 million are men. The larger proportion of older women who have AD 
and other dementias is explained primarily by the fact that women live longer, on average, than 
men. See Figure 4. People with fewer years of education appear to be at higher risk for AD and 
other dementias than those with more years of education. Data indicates that, in the United 
States, older blacks are probably about twice as likely to have AD and other dementias as older 
whites, and Hispanics are about 1.5 times as likely to have AD and other dementias as older 
whites (Thies & Bleiler, 2013). 




Alzheimer's Disease Breast cancer 
(Age 65) (Age 60) 
Source: (alz.org) 
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The increasing level of education among older adults over the past 20 years may influence 
the prevalence and outcomes of dementia in the future. Currently, the proportion of adults over 
65 with a high school diploma increased from 53.0% in 1990 to 72.0% in 2003, whereas the 
proportion with a college degree increased from 11.0% to 17 .0% during this same period. More 
years of formal education are associated with a reduced risk of dementia, likely through multiple 
causal pathways, including a direct effect on brain development and function (i.e., the building of 
"cognitive reserve"), better health behaviors, and the general health advantages of having more 
wealth and social opportunities (Rocca et al., 2011 ). 
Despite some evidence of racial differences in the influence of genetic risk factors on AD 
and other dementias, genetic factors do not appear to account for these large prevalence 
differences across racial groups. Instead, health conditions such as high blood pressure and 
diabetes mellitus, which may increase one's risk for AD and other dementias, are believed to 
account for these differences because they are more prevalent in black and Hispanic people. 
Lower levels of education and other socioeconomic characteristics in these communities may 
also increase risk (Thies & Bleiler, 2013). 
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While prevalence is the number of existing cases of a disease in a population at a given 
time, incidence is the number of new cases of a disease that develop in a given time period. The 
estimated annual incidence (rate of developing disease in 1 year) of AD appears to increase 
dramatically with age, from approximately 53 new cases/I 000 people age 65 to 74 years, to 170 
new cases/1000 people age 75 to 84 years, to 231 new cases/I 000 people age 85 years and older 
{Thies & Bleiler, 2013). 
Current Expenditures for Alzheimer's 
The cost of Alzheimer's is enormous. In 2014 Medicare and Medicaid estimated they 
would spend $150 billion for health care and long-term care cost for people with Alzheimer's 
and related dementias. Not included in that figure is the 36 billion patients, families, and 
caregivers would have to pay during that same time. The annual cost of care for someone with 
Alzheimer's is nearly $47,000. That is three times the amount than someone who does not have 
the disease. In addition to the out of pocket costs, more than 15 million people will provide 17. 7 
billion hours of unpaid caregiving time, valued at $220 billion (Alzheimer's Association National 
Plan Milestone et al., 2014). 
Another concern is those with dementia might be more likely to be readmitted shortly 
after hospital discharge. To varying degrees, dementia impairs patients' abilities to benefit from 
discharge education; adhere to instructions regarding after-hospital care; or report symptoms, 
potentially delaying the diagnosis and treatment of conditions such as urinary tract infections, 
congestive heart failure, and pneumonia, where timely outpatient management may avoid 
hospitalizations {Daiello et al., 2014). 
Looking at dementia globally is also a factor of concern. In the 2010 report, Alzheimer's 
Disease International estimated the global economic impact of dementias to be US$604 billion. 
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The report illustrates this in terms of comparisons with the turnover of companies in that year. If 
this level of cost were income, this would make dementia the world's largest company by 
turnover, bigger than Wal-Mart and Exxon Mobil. If dementia were a company it would be the 
world's 18th largest economy. Currently, 90% of the global costs of dementia fall to the 
developed world with 70% attributable to Western Europe and North America; at present less 
than one percent of costs are borne by low-income countries. However, this will change 
predictably and change quickly (Banerjee, 2012). 
Palliative Care Outcome Measurements 
Palliative care outcomes can be measured in several different ways. They can be 
measured in dollars spent versus money saved, desired health outcomes of the patient, degree of 
patient satisfaction, and degree of provider satisfaction. Each hospital measures outcomes 
differently. Initially programs focus on dollars spent versus saved while more established 
programs are concerned with patient and provider satisfaction. 
Morrison et al. (2008) analyzed administrative data from 8 hospitals with established 
palliative care programs for the years 2002 through 2004. Patients receiving palliative care were 
matched by propensity score to patients receiving usual care. Generalized linear models were 
estimated for costs per admission and per hospital day. Of the 2966 palliative care patients who 
were discharged alive, 2630 palliative care patients (89%) were matched to 18,427 usual care 
patients, and of the 2388 palliative care patients who died, 2278 (95%) were matched to 2124 
usual care patients. The palliative care patients who were discharged alive had an adjusted net 
savings of$1696 in direct costs per admission (p = .004) and $279 in direct costs per day (p < 
.001) including noteworthy reductions in laboratory and intensive care unit costs compared with 
usual care patients. The palliative care patients who expired had an adjusted net savings of $4908 
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in direct costs per admission (p = .003) and $374 in direct costs per day (p < .001) including 
significant decreases in phannacy, laboratory, and intensive care unit costs compared with usual 
care patients. See Figure 5. 
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Figure Legend: Mean direct costs per day for palliative care patients who were discharged alive (A) or died (B) 
before and after palliative care consultation. The solid line represents the regression curve of actual costs before 
palliative care consultation (day 0) and estimated costs (days 1-6) assuming that palliative care consultation had not 
occurred. The dashed line represents direct costs per day for usual care patients for the 6 days before and after 
hospital day 6 (patients with lengths of stay of :::;IO days), hospital day IO (for patients with lengths of stay of 11-20 
days), or hospital day 18 (for patients with lengths of stay of>20 days). 
Morrison et al. (2011) went on further to look at Medicaid patient data of four New York 
hospitals from 2004 to 2007. On average, patients who received palliative care incurred $6,900 
less in hospital costs during a given admission than a matched group of patients who received 
usual care. These reductions included $4,098 in hospital costs per admission for patients 
discharged alive, and $7,563 for patients who died in the hospital. Consistent with the objectives 
of patients and their families, palliative care recipients spent less time in intensive care, were less 
likely to die in intensive care units and were more likely to obtain hospice referrals than the 
matched usual care patients. 
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For many hospitals, patient and family satisfaction is a focus. There are several themes 
when measuring such satisfaction. Nelson et al. (2010) completed a study with nine focus 
groups, across three sites. One of the most common themes found among the participants was 
communication between clinicians and patients and their family members. The wife of a patient, 
who reported receiving frequent and effective communication in meetings that included the ICU 
physician, bedside nurse, and hospital chaplain, stated, "It's very important that you know every 
day what is happening, because every day in an ICU is different." 
A second theme is self-efficacy. Self-efficacy can be defined as "the competence 
perceived by family members in participating in the care of the dying person." In comparison to 
family members of usual care patients, family members of palliative care patients were more 
likely to report that they were fairly to very confident that they knew what to do when the patient 
died (usual care 64 [71%] vs. palliative care 46 [87%],p = 0.03). A trend was observed favoring 
palliative care in response to items querying whether families knew what to expect when the 
patient was dying (68% of usual care families felt very confident [n 55] vs. 82% of palliative 
care families [n 42],p = 0.07). Overall, palliative care showed significant benefit in the self-
efficacy domain, with 52 (56%) of family members of usual care patients reporting that they 
were not confident in one or more of the above subdomains, as compared to 18 (33%) family 
members of palliative care patients (p = 0.03) (Gelfman, Meier, & Morrison, 2008). 
Another concern regarding satisfactions is how staff relates to palliative care. A study 
was completed at a single hospital seeking to improve palliative care quality in the ICU. The 
study identified consecutive patients who died in the ICU (n = 253) before an intervention and 
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post-intervention (n = 337). The intervention consisted of clinician education, local champions, 
academic detailing, feedback to clinicians, and system support. Using the Quality of Dying and 
Death (QODD) surveys and hierarchical linear modeling for the results showed an increase in 
nurse satisfaction (pre, 63 .1; post, 67 .1; p < 0.01) along with notable decrease in ICU days prior 
to death (pre, 7.2; post, 5.8; p < 0.01) (Curtis et al., 2008). 
Enguidanos, Vesper, and Lorenz (2012) competed a retrospective cohort study to identify 
factors associated with hospital readmissions among seriously ill patients who received and 
inpatient palliative care consultation. Administrative data was collected utilizing medical service 
records. Additionally, records of pain at discharge and disposition at discharge were also 
collected. Disposition could include home with hospice care, nursing facility, home-based 
palliative care, home without home care services, and home with home health care. The 
difference between home with hospice and home with palliative care was the palliative care 
services were used if the patient was expected to live longer than a year and hospice was used if 
patients were expected to live less than six months. Descriptive analysis was used to describe the 
sample along with t tests and x2 tests to compare characteristics of those who were not 
readmitted. Multiple hotdeck imputation was used for all variables with missing data. Logistic 
regression determined the factors associated with 30-day hospital readmission, adjusting for 
covariates. The results showed 484 patients aged 65 and over received IPC consults. Among 
these, 45 (9.3%) died during hospitalization, and 31 (6.4%) had missing medical service or 
disposition data, leaving 408 in the analytic sample. The mean age was 80.1 years (standard 
deviation [SD]= 8.2) and about half (48.5%) were female. The sample was diverse: 37.5% were 
white, 22.5% Latino, 20.3% black, 7 .8% were of other ethnic background, and 11.8% had 
missing data. Cancer was the most common primary diagnoses (34.3%) followed by congestive 
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heart failure (CHF) (16.4%), dementia (11.8%), coronary artery disease (11.8%), and chronic 
obstructive pulmonary disease (COPD). More than half (58.8%) were discharged to hospice, 
14.7% to home-based palliative care, 14.2% to a nursing facility, 8.6% to home with no care, and 
3.7% to home with home health. Nearly all (99.2%) admissions to hospice or home-based 
palliative care were new referrals. 
Overall, 10.0% of those discharged from the hospital were readmitted within 30 days. 
Additionally, 30-day readmitted patients were more likely to have no emergency contact or a 
distant relative as an emergency contact. They also were more likely to be discharged without 
care at home or to a nursing facility. Among the 41 patients readmitted within 30 days, more 
than half (51 %) were readmitted within 5 days and 78% were readmitted within 10 days of 
hospital discharge (Enguidanos et al., 2012). 
With studies like the ones mentioned above, a greater appreciation for the benefits 
provided by inpatient palliative care consultations is developing. Providers should realize that an 
IPC coupled with a discharge for hospice or palliative care results in lower hospitalization 
readmission rates. 
Alzheimer's Disease and Comorbidities 
Palliative care for those with Alzheimer's disease is a growing concept. Most people 
think of cancer when palliative care is discussed. Most immediate causes of death recorded on 
autopsies are pneumonia, cardiovascular events and pulmonary embolism. Others can include 
cachexia and dehydration (Aminoff & Adunsky, 2004). Phelan, Borson, Grothaus, Balch, and 
Larson (2012) studied 494 patients with dementia. Of those, 427 (86%) were admitted to the 
hospital at least once for associated conditions. Among participants with dementia, the average 
annual admission rate was 419 admissions per I 000 persons, more than twice that of those 
without dementia, who averaged 200 admissions per 1000 persons each year (crude rate ratio, 
2.1 O; 95% Cl, 1.87- 2.35; p < .001 ). After age and sex adjustment, the ratio of admission rates 
was 1.57 (95% CI, 1.39-l.78;p < .001) and was 1.41 (95% Cl, 1.23-l.6l;p < .001) after 
adjusting for additional covariates. 
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Individuals with Alzheimer's disease are at an increased risk for under-treatment due to a 
lack of knowledge and respect for the disease process. It is often too complex and nuances of the 
condition are unknown to many who are responsible for treating the disease. Those with 
Alzheimer's, due to their comorbidities have greater and long-lasting burden with pain, anxiety, 
constipation, pressure sores, and restraints. Additionally the disease often causes behavioral 
changes, which prompt some health professionals interpret as behavioral symptoms of the 
disease or the person is "just being cranky" (Mabon & Sorrell, 2008). 
Barriers to Implementation 
There are several barriers to implementing palliative care in hospitals. First, there is lack 
of public awareness. If not educated on what palliative care entails, the public automatically 
equates it with a life-limiting concept. Medical centers need to educate patients, especially those 
with chronic complex conditions and comorbidities, that a palliative care service is available to 
them to assist in streamlining their care (Verret & Rohloff, 2013). 
The second barrier is lack of understanding from medical care administrators. Some 
organizations think palliative care is just for end-of-life patients or a means to reduce length of 
stay. They do not understand how costs can be controlled by managing and coordinating care in 
the acute, inpatient, and outpatient settings. There needs to be further training on how palliative 
care can be achieved at all levels. Through this continuwn of care, high patient satisfaction, 
better medical outcomes, and a reduced length of stay can all be achieved (Verret & Rohloff, 
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2013). Grudzen et al. (2013) looked at barriers in the emergency department and found one ED 
administrator who stated, "If you have this conversation right at the portal of entry and the 
person does get stabilized, how wonderful; or ifthe disease takes its natural progression, it'll be 
expected instead of the family thinking something was done wrong." 
The third barrier is acceptance from primary care physicians. Although each patient's 
well-being is the focus of the primary care physician, often physicians simply cannot 
synchronize schedules to speak at length with all family members, guardians, or other physicians 
regarding vital care decisions. Palliative care teams offer a mechanism for introducing these 
conversations. However, from the primary physician's point of view they are often seen as taking 
charge of the patient. Introducing the patient and family to the palliative care team should be 
viewed as an equivalent to referring the patient to a specialist (Verret & Rohloff, 2013). Gunvon, 
Gunten, and Weissman (2013) state, "although the focus of the consultation is a patient/family 
issue, your primary stakeholder is the attending physician who requested the consultation. 
Unhappy referring physicians mean fewer palliative care consultations!" 
The fourth barrier is lack of standardization. Even though palliative care teams have 
grown, the effectiveness of their processes continues to lag. There is an absence of 
standardization in regards to structure, staffing, and policies. Many hospitals require a "pull" 
strategy where an order has to be written for a palliative care consult. Other facilities allow staff 
nurses to initiate a referral after a screening process has been completed. Most critical to 
standardization is the ability to move past internal politics that could obstruct streamlined 
integration with standard of care (Verret & Rohloff, 2013). Grudzen et al. (2013) found 
administrators suggested that hospitals adopt an algorithm or set of benchmarks to reduce 
variation in who receives palliative care interventions. An ED nursing director recommended 
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creating "a system that sets a pathway for patients who present under a certain set of 
circumstances" so that a patient's experience is not "random and variable." Barriers specific to 
ED leadership include poor communication with patients and families, medico-legal concerns, 
and a lack of clear recommendations for forgoing care interventions or aggressive symptom 
management. Clear guidelines would help patients reach destinations, whether inpatient or 
outpatient, that are matched to their needs. This might also reduce medico-legal concerns ifthere 
are guidelines and processes for relinquishing aggressive interventions for patients who are 
unlikely to benefit. 
Policy for the Future of Alzheimer's 
Change must happen in order for the battle to be won against Alzheimer's disease. It will 
take effort from government officials, healthcare researchers and providers, and families of those 
who are stricken with the disease. Without all three groups of people working together, the 
struggles will continue for those who have Alzheimer's. 
Government Officials 
Since the passage of NAP A, the current administration has done more to advance 
Alzheimer's research than has any prior administration, as a result of both its implementation of 
the act and its reallocation of resources for Alzheimer's research in fiscal years 2012 and 2013. 
Yet these accomplishments will not in and of themselves be sufficient to achieve the Alzheimer's 
Study Group's aim nor the national plan's 2025 goal. Research in cognitive decline and brain 
health have led to a better understanding of Alzheimer's and its progression, but identifying the 
underlying cause of the disease, effective treatments, and a cure requires further investment. The 
National Institutes of Health (NIH) has the ability to influence how much scientific research is 
directed at these questions through its funding decisions. Once new drugs or treatments are 
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developed, the Food and Drug Administration (FDA) sets policies that dictate what type of data 
are needed to win regulatory approval (Bynum, 2014). These decisions must be expedited in 
order for us to gain control of this disease by 2025. 
Clinical trials for Alzheimer's disease now target people before they develop overt disease, 
which makes the measurement of the treatment effect challenging. Recently, the FDA issued 
draft guidance to address this issue for newer studies of Alzheimer's disease therapies. In 
addition to research into the biology of Alzheimer's disease, there is also a need for ongoing 
research on how best to organize, deliver, and finance care in ways that provide the best quality 
of life possible for people affected by the disease (Bynum, 2014). Very soon phase III studies 
using drugs acting against amyloid deposition will be completed in patients with mild to 
moderate dementia due to AD. Although it is difficult to predict the outcomes, it is appropriate 
for this discussion to consider the issues possibly facing us if one of the treatments is effective to 
delay progression to moderate dementia, at least in a group of responders that can be defined 
using genotype (such as ApoE), age of onset of symptoms, and severity of dementia at time of 
treatment initiation (Gauthier, Leuzy, Racine, & Rosa-Neto, 2013). 
Payment policy and regulatory functions in Medicare clearly have direct implications for 
people living with dementia, as they do for older adults with any disease. Some policies focus 
specifically on Alzheimer's disease and related dementias, such as eligibility criteria for entry 
into hospice and decisions guided by the Medicare Evidence Development and Coverage 
Advisory Committee about whether to cover new diagnostic imaging and testing technologies. 
The development of new payment strategies that create incentives for better care coordination 
and that reduce hospital readmissions is not specific to Alzheimer's disease and related 
dementias. Nonetheless, those strategies could have a large impact on people with dementia 
because they tend to have multiple chronic conditions and are at high risk of hospitalization 
(Bynum, 2014). 
Healthcare Researchers and Providers 
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Festic, Wilson, Gajic, Divertie, and Rabatin (2012) conducted a study determining the 
different viewpoints of care providers. In order to implement change, we have to learn from our 
mistakes. Festic and colleagues identified five areas of difference between end-of-life care 
(EOLC) assessments of nurses and physicians. They found that nurses felt that they were unable 
to safely voice concerns regarding EOLC policies and practices, while physicians felt more 
comfortable in doing so. Additionally, they found that physicians were more likely to agree than 
nurses that appropriate and timely discussions regarding health care directives and do not 
resuscitate (DNR) orders were taking place. Physicians were more likely than nurses to agree 
that spiritual assessments were completed and that members of the medical team were aware of 
such assessments. Addressing spiritual needs is a core component of providing quality EOLC. 
Second, nurses often perceive that conflicting information and opinions are given to patients and 
their families by various physicians caring for the same patient. Third, a lack of communication 
may also contribute to dissatisfaction among nurses. Fourth, when presented with a patient 
scenario, ICU nurses seem to experience higher levels of moral stress as compared to physicians. 
In one study, 45% of nurses considered leaving a position secondary to moral stress, compared to 
only 3% of physicians. Nurses also spend more time with patients and may be more acutely 
aware of suffering. Lastly, there are further contributing factors that may include differences in 
authority, education, and work philosophies. Each of these causes of discrepancy represents an 
opportunity for intervention. Additional outcomes such as poor comprehension, anxiety and 
depression have been reported when successful physician and nurse collaboration are absent. 
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Education should include families of patients with Alzheimer's disease and the wider 
community: physicians, hospital staff, long- term care professionals, and hospice staff. The 
themes for the education should include general knowledge about severe dementia and 
recognition of advanced AD as a terminal condition. Improved awareness of the social support 
provided to the families during a residential hospice stay and during bereavement is needed. 
Hospice staff training is necessary in regards to the unique needs of individuals with AD 
including how to communicate and how to manage behavioral symptoms of dementia. Overall 
public education on the terminality of AD and the benefits of hospice care need to continue to be 
encouraged from both the Alzheimer's Association and hospice agencies (McCarty & Volicer, 
2009). 
Families and Friends 
Unfortunately, patients with dementia are at particular risk for receiving poor end-of-life 
care for a variety of reasons. A primary factor is that few patients. with dementia are ever 
enrolled in hospice care, the dominant model of providing superb end-of-life care in this country. 
Few patients enrolled in hospice have a primary diagnosis of dementia. Underutilization of 
referral to hospice for these patients may be related to a lack of recognition of dementia as a 
terminal disease, and the difficulty in quantifying a prognosis of six months or less. To combat 
this dire statistic, The University of Chicago developed the Palliative Excellence in Alzheimer 
Care Efforts (PEACE) program. It attempts to integrate palliative care into the primary care of 
patients with dementia throughout the course of the illness. This program essentially 
demonstrates a disease management model for dementia that incorporates advance planning, 
patient-centered care, family support, and a palliative care focus from the diagnosis of dementia 
through its terminal stages. In addition, in the advanced stages of the disease, the PEACE 
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program strives to ensure that all patients and families are offered hospice care, that patients die 
in their desired location (usually at home), and that they do not undergo undesired invasive 
procedures or hospitalizations (Shega et al., 2003). This program needs to serve as a model and 
be implemented in all communities to better serve those who have Alzheimer's. A possible 
solution would be to have each local Alzheimer's Association chapter spearhead the PEACE 
program in their community. 
For Further Research 
End oflife care is an increasingly important health care issue, and represents a significant 
burden of costs to the society. Palliative care provides a counterintuitive attitude to the high-tech 
American model of health care. Nevertheless, current limited data shows that investing in 
palliative care makes more sense both ethically and financially. What is smprising, 
unfortunately, is the lack of public understanding and emphasis on palliative care, the gaps in 
implementing what is cost-effective in end oflife care, and in training palliative care 
professionals, and the vast deficits in palliative care research support to find effective solutions 
(Yang & Mahon, 2012). 
Definitions, methods, and measurement strategies vary across studies limiting our ability 
to address sources of fault. We must therefore address methodological vulnerabilities and 
develop a foundation of meticulous research that adds to the evidence base and helps enhance 
patient and family outcomes during the receipt of palliative and end-of-life care. Longitudinal, 
prospective, theoretically driven designs offer opportunities to consider causal mechanisms and 
explore mediators, confounders, and interaction effects. We also must avoid unclear definitions, 
better assess health disparities, and use theoretical frameworks. Comparative effectiveness and 
cost-effectiveness studies, and those that address topics such as advanced care planning, pediatric 
issues, and ethno-culturally diverse populations must also be conducted utilizing the best 
methodology possible (Aziz, Miller, & Curtis, 2012). 
METHODOLOGY 
Study Design and Hypothesis 
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We conducted a retrospective archival inception cohort study using hospital 
administrative claims data from the state of Florida for the calendar year of2012. The study 
design was approved by the Medical University of South Carolina Institutional Review Board as 
an exempt activity of human subjects research. 
We selected only acute care patients in Florida with a diagnosis of Alzheimer's disease or 
dementia who were hospitalized for either the dementia condition or because of acute urinary 
tract infection (UTI), pneumonia, congestive heart failure (CHF). This limitation in primary 
reasons for hospital admission allowed us to examine the effect of the palliative care consult for 
a homogenous group of patients who would be expected to be at similar risk of readmission at 30 
days. 
In the present study, two hypotheses will be examined. They are described below. 
Hypothesis 1: Inpatient Palliative Consultations will reduce hospital readmissions 
for patients who are suffering from Alzheimer's disease and dementia. This study will show 
the benefit of utilizing IP Cs in regards to costs, lengths of stay for initial admissions, and 
reductions in re-admissions. 
Hypothesis 2: This study will show the effect of the inpatient palliative care 
consultations has on reducing re-hospitalization is reduced as the number of comorbidities 
increases. 
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Population and Sample 
For the data used in the present study, the original population consisted of 53,574 
admissions of patients with Alzheimer's disease from January 1, 2012 through December 21, 
2012 to any Florida hospital. Readmissions from all causes within 30 days were 8009. Of the 
initial 53,574 admissions, 2,238 had palliative care consultations, which is a focal aspect of the 
proposed study. 
Def'mition of Variables 
In addition to demographic variables, there will be seven measured variables in the 
present study. Each is described below. 
Demographics. Sex will be coded 0 for males and I for females. Race will be coded 0 for 
Whites, 1 for Blacks, 2 for Hispanic, and 3 for others. 
Admission. Admission was characterized by the index hospitalization for a person 
diagnosed with Alzheimer's disease using ICD-9 code 331.0 or dementia using ICD-9 code 
290.xx. 
Readmission. Hospital readmissions will be the focal dependent variable. Hospital 
readmission is defined as an admission into the hospital 30 days from the index hospitalization 
date. Thus, this variable is binary and will be coded as I = Yes and 0 = No. 
Palliative care. The main independent variable will be the Inpatient Palliative Care 
consultation code. For those who had the IPC code ofV66.7, a 1 will be entered in the data set. 
For those who did not receive an IPC, a 0 will be entered. While the intensity of the consultation 
cannot be determined by this value, it does constitute a change in care process. 
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Hospice Care. Hospice care is defined as patients who received or did not receive a 
referral to hospice care. Those who received a referral will be assigned the value of 1. For those 
who did not receive a referral, there value will be 0. 
Reason for Admission. This variable will index the number of diagnoses for which the 
patient was admitted. Although 11 possible diagnoses will be coded (see below), some overlap, 
resulting in nine unique codes. Because the reason for admission variable will be a sum, this 
variable will range between 1 and 9 where 1 indicates one diagnosis while 9 indicates that a 
patient was admitted based on all 9 diagnoses. The possible diagnoses coded are: 
331.0 - Alzheimer's disease 
290.xx - Dementia 
428.0 - Congestive Heart Failure 
487.0-lnfluenza with pneumonia 
482.83 - Pneumonia due to other gram-negative organisms 
481 - Pneumococcal pneumonia 
486 - Generic bacterial pneumonia 
595.4 - Cystitis in diseases classified elsewhere 
595.0 - Acute Cystitis 
595 - Cystitis 
599.0- Urinary tract infections 
Payer Source. The source of the payer will take one of three values. Medicare will be 
coded as 0, Medicaid will be coded as 1, and Commercial Insurance would be coded as 2. 
Length of stay (LOS). Length of stay will be defined as the number of days the patient 
was in the hospital from admission to discharge. 
Data Collection 
Information was retrieved from the public use data sets from the Healthcare Cost and 
Utilization Project (HCUP) provided by the Agency for Healthcare Research and Quality 
(AHRQ) specifically for the state of Florida from 2012. Unlike most other states, Florida was 
selected because they are able to link subsequent admissions back to initial admissions using 
patient identification numbers. Daiello, Gardner, Epstein-Lubow, Butterfield, and Gravenstein 
(2014) in their study of Alzheimer's readmission rates uses Rhode Island data for the same 
reason. Only few states provide the linkage between initial admission and readmission data. 
Analysis 
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Data set construction and analyses were performed using SAS v 9.3. Mean values and 
percentages were used for description of our population. We tested differences between groups 
using chi-square, t-test, or non-parametric statistics as appropriate. Multivariable modeling was 
performed using logistic regression. We controlled for differences in patient characteristics; 
including principal diagnosis and other variable that were significantly different in the univariate 
comparisons. We first fitted a complete model using all control variables. Then we removed the 
non-significant predictors one at a time and re-estimated the model until the model diagnostics 
were optimal. 
RESULTS 
There were a number of patient characteristics that did not differ significantly between 
palliative care patients and non-palliative care patients (see Table I). They were similar in their 
gender and race distributions as well as the average number of chronic conditions. However, 
those who received palliative care were significantly older (85.9 vs. 83.5 years p < .0001) than 
those who did not receive palliative care. In addition, although patients were more likely to be on 
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Medicare than other forms of insurance, those without palliative care were almost entirely on 
Medicare (94.7%) compared to those with palliative care (76.5%) and this association was 
statistically significant (p < .0001). 
Regarding other characteristics, it deserves noting that dementia type was also associated 
with whether a patient received or did not receive palliative care. More specifically, a slightly 
larger percentage of palliative care patients had Alzheimer's (82. l % ) compared to non-palliative 
care patients (77.0% p = .0173). We also found a different distribution of index admission 
principal diagnosis for patients who received palliative care. In particular, palliative care patients 
had more admissions for pneumonia and sepsis while non-palliative care patients were more 
often admitted for urinary tract infection or pneumonia (p < .0001 ). There were substantial 
differences in discharge destination between groups. Patient without palliative care were more 
often discharged to a nursing home (47.2%) or home (32.9%) while those with palliative care 
consults tended to be discharged to a hospice (55.2%) or other setting (28.4%) (p <.0001). As 
expected, length of stay was significantly shorter for palliative care patients (5.3 vs. 6.8 days p < 
.0001) and cost was also substantially lower for palliative care patients ($8,385 vs. $9,401 p < 
.0001) than for non-palliative care patients. 
Table 1: Patient Characteristics at the Index Admission 
Variable Names Patients with a Patients Statistic Total 
Palliative Care without Population 
Code Palliative Care N=7308 
N=408 N=6900 
Patient Characteristics: 
Mean~e(SDl 85.9 _(8.2) 83.5_(8.31 <.0001 83.6_{_8.27) 
Percent Female 60.5% 59.5% .8285 59.5% 
Percent White 69.6% 68.1% .5138 68.2% 
Percent Black 7.8% 9.9% .1830 9.7% 
Percent Other Race 22.6% 22.1% .8270 22.1% 
Mean (SD) Number of 7.0 (3.6) 7.2 (3.3) .2615 




Medicare 76.5% 94.7% <.0001 93.7% 
Medicaid 0.3% 1.6% 1.6% 
Commercial Insurance 9.8% 2.3% 2.7% 
OtherP~ers 13.5% 1.4% 2.0% 
Dementia T_He: 
Alzheimer's 82.1% 77.0% .0173 77.3% 
Dementia 17.9% 23.0 22.7% 
Index Admission 
Princ!P_al Diagnosis: 
Urin~ Tract Infection 13.7% 31.5% <.0001 30.5% 
Pneumonia 29.9% 29.0% 29.0% 
Sepsis 29.4% 16.1% 16.9% 
Cong_estive Heart Failure 9.3% 11.7% 11.5% 
Alzheimer's or Dementia 17.7% 11.7% 12.1% 
Dischar_g_e Destination: 
Dischar__g_ed to Home 4.4% 32.9% <.0001 31.3% 
Dischar__g_ed to Ho~ce 55.2% 9.3% 11.9% 
Discharged To Nursing 12.0% 47.2% 45.2% 
home 
Discharged to other 28.4% 10.6% 11.6% 
settin__g_s 
Percent with Palliative 100% 0% NA 5.58% 
Care Consult 
LOS on Index Admission 5.3 f4.7) 6.8 (7.71 <.0001 6.7 (7.5) 
Cost of Index Admission $8,385 $6,401 .0447 $9,344 
1$9,8091 ($11,35~ _{_$11,275) 
Of the 7308 patients in our study, 1266 (17.3%) were readmitted within 30 days (see 
Table 2). However, only 1.9% of the readmitted patients had received an IPC during the index 
admission. 
Readmitted patients were, on average, younger (82.6 year vs. 83.8 years p < .0001) 
patients who were not readmitted. Of those who were readmitted, 64.5% were white, which was 
significantly less than the 68.9% who were white and not readmitted (p = .0024). Notably, of 
those who were readmitted, 11.4% were black, which was significantly greater than the 9.4% 
who were black and not readmitted (p = .0313). In addition, of those who were readmitted, 
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24.9% were non-black minorities compared to 21. 7% who were not readmitted. As expected, 
those were readmitted also tended to have a greater average number of chronic conditions (7.8 
vs. 7.1 p < .0001) compared to those were not readmitted. The type of insurance was also 
associated with readmission status with Medicare and Medicaid insurance coverage was more 
prevalent for those who are readmitted compared to those who are not readmitted (p = .0079). In 
summary, those who were readmitted within 30 days were less likely to have received a 
palliative care consult, were younger, more likely to be black or some other minority race, and 
have a larger average number of chronic conditions. 
Table 2: Characteristics of Patients by Readmission at 30 Days 
Variable Names Readmitted by 30 No Readmission Statistic 
Days Patients N=6042 
N= 1266 
Percent with Palliative Care 1.9% 6.4% <.0001 
Consult 
Patient Characteristics: 
Mean E!8_e _iSDl 82.6_i8.~ 83.8_(8.U <.0001 
Percent Female 57.7 59.9 .1348 
Percent White 64.5 68.9 .0024 
Percent Black 11.4 9.4 .0313 
Percent Other Race 24.9 21.7 .0062 
Mean (SD) Number of Chronic 7.8 (3.4) 7.1 (3.6) <.0001 
conditions noted on record 
Insurance: 
Medicare 94.2 93.6 .0079 
Medicaid 2.3 1.4 
Commercial Insurance 2.3 2.8 
Other Payers 1.2 2.2 
Dementia T__IP_e: 
Alzheimer's 71.9 76.2 .0012 
Dementia 28.l 23.8 
Index Admission Principal 
Diagnosis: 
Urin..!!!Y_ Tract Infection 30.9 30.4 <.0001 
Pneumonia 28.0 29.3 
Sepsis 14.7 17.4 
Con_g_estive Heart Failure 16.0 10.6 
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Alzheimer's or Dementia 10.4 12.4 
Dischar_g_e Destination: 
Dischar__g_ed to Home 33.l 30.9 <.0001 
Dischar__g_ed to Ho~ce 2.7 13.8 
Dischar__g_ed To Nursin__g_ home 56.6 42.8 
Dischar_g_ed to other settin_g_s 7.6 12.5 
Index Admission Resources: 
LOS on Index Admission 8.4 (11.21 6.3_{_6.41 <.0001 
Cost of Index Admission $11,3961$10,584) $8,915 ($8,6531 <.0001 
There were additional differences between the readmitted patient group and those not 
readmitted within 30 days. The readmission group had a low proportion of patient with 
Alzheimer's disease (71.9% vs. 76.2% p = .0012) than patients who were not readmitted. In 
addition, patients with an index diagnosis of congestive heart failure were much more likely to 
be readmitted than patients with other index diagnoses (p < .0001). The discharge destination for 
the Index admission also affects the risk of readmission within 30 days. Patients who were 
originally discharged to home or a nursing home were more frequently readmitted than patients 
who were discharges to hospice or other sites (p < .0001 ). Patients with a longer LOS during 
the Index admission were also more likely to be readmitted than patients with a low LOS. The 
average LOS at the original admission for those were readmitted was 8.4 days compared to 6.4 
days for those who were not readmitted (p < .0001 ). The average cost was $11,396 vs. $8,915 (p 
< .0001). 
These descriptive statistics indicate that the characteristics of patients who were 
readmitted differ greatly, both in terms of their use of IPC and by many other factors. To clarify 
the contribution of IPC to the reduction of readmissions, we used multi variable modeling to 
examine the effect of IPC on readmission risk controlling for all the characteristics shown above. 
The results of the multivariable modeling are provided in Table 3. 
We examined the ability of having a recorded palliative care consult recorded from the 
hospital discharge summary on the risk of readmission within 30 days for our patient cohort 
using logistic regression modeling of readmissions within 30 days (readmission = 1, no 
readmission= 0). The results of the comprehensive multivariable model (Model 1) and best 
fitting model (Model 2) are provided in Table 3. The most parsimonious model is discussed 
below. 
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The overall fit of the reduced model was statistically significant (p < .0001). The 
estimated odds ratio (OR) for palliative care was 0.56, indicating that patients who receive 
palliative care are about 44% less likely to be readmitted. Several variables were shown to affect 
risk of readmission in the model. Readmission risk decreased for older patients. For each 
additional year in age, the odds of being readmitted decreases by 1.3%. Hispanic patients were at 
about 22% greater risk than either Caucasian or African American patients with and OR of 1.22. 
Being discharged to a nursing home at the end of the Index admission increased the risk of 
readmission by 39% (OR= 1.39), while discharge hospice decreased readmission risk by 76% 
(OR= 0.24) compared to patients who were discharge to home or to other settings. Patients who 
were hospitalized for CHF during the Index admission had 54% greater risk of a readmission 
within 30 days, than observed for patients with any of the other diagnoses (OR 1.54 ). As we 
expected, patients with a greater number of chronic conditions were at greater risk of 
readmission. For a one unit increase in the number of chronic conditions recorded, the odds of 
being readmitted increases by 4.2%. LOS for the Index admission was also a predictor of 
increased risk of readmission, for a one-unit increase in the LOS, the odds of being readmitted 
increase by 2.6% (OR = 1.026). 
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T bl 3 Multi ri bl L . ti R Mdl Prditin Rd. i t30D a e . VB a e 021s c egress1on o es e c ~ ea nuss on a ~ . 
Variable Names Model 1: OR Model2: OR Model 2: 
All Variables Only Significant 95%0R 
Readmitted Variables Retained Confidence 
by 30 Days Readmitted by 30 Interval 
d~s 
No Palliative Care Consult 
ref!!.rence 
Palliative Care Consult 0.697 0.557 0.362-0.858 
Patient Characteristics: 





Hi~anic 1.247 1.220 1.053-1.413 
Number of Chronic conditions 1.039 1.038 1.018-1.058 




Commercial Insurance 1.212 
Other Pa~rs Re~rence 
Index Admission Principal 
Diaposis: 




Con_g_estive Heart Failure 1.407 1.527 1.270-1.836 
Alzheimer's or Dementia 0.851 
Dischai:g_e Destination: 
Dischar_g_ed to Home 1.894 
Dischar_g_ed to Hos_P!ce 0.379 0.235 0.164-0.338 
Dischar_g_ed To Nursin_g_ home 2.292 1.392 1.225-1.583 
Discharged to other settings 
ref!!.rence 
Index Admission Resources: 
LOS on Index Admission 1.029 1.026 1.016-1.035 
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DISCUSSION 
This study examined readmission rates specifically for those individuals with 
Alzheimer's disease or dementia that also had an IPC. Due to recent healthcare legislations and 
penalties assessed by Medicare on hospital readmission rates, this study was necessary. Daiello, 
Gardner, Epstein-Lubow, Butterfield, and Gravenstein (2014) examined patients specifically 
readmitted with Alzheimer's and found an alarming readmission rate of 17.8%. Other 
researchers like Gaertner et al. (2013), Cheng, Dy, Fang, Chen, and Chiu (2013), Armstrong, 
Jenigiri, Hutson, Wachs, and Lambe (2013) have studied the effects of IPCs on hospital 
readmission rates, typically for those with cancer. However, to our knowledge, this is the first 
article that brings IPCs and Alzheimer's together. While the results showing the effectiveness of 
having inpatient palliative care consultations as part of the process of care for those with 
Alzheimer's, further research needs to be completed. Specifically, education for hospital staff on 
palliative care screening, education for family members on the progression of Alzheimer's 
disease, and better resources in the planning for transitions in care as a patient's needs change. 
LIMITATIONS 
Although the findings of this study were consistent with predictions based on the 
literature, there were limitations. The accuracy of coding diagnosis and documentation of the 
palliative care consultation may not be consistent across hospitals. Only one year of data was 
analyzed in one state. Perhaps to make this study more generalizable, more years and different 
states could be included in future studies. Finally, the depth of the inpatient palliative care 
consultation cannot be determined, only that a change in the process of care occurred. Rural 
hospitals may have a different palliative care program than academic teaching hospitals. Through 
this research, we are unable to determine the depth or breadth of the IPC. 
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The Effect of Inpatient Palliative Care Consultations on Hospital Readmission Rates for Patients 
with a Diagnosis of Alzheimer's Disease or Dementia 
ABSTRACT 
Background: Evidence suggests that inpatient palliative care consultation (IPC) services reduce 
the likelihood of hospital readmissions for those with Alzheimer's disease and dementia. 
Objective: This study examines the difference in readmission rates for Alzheimer's patients with 
and without inpatient palliative care consultations. 
Design: This is a retrospective study using an inception cohort derived from HCUP archival data 
from the state of Florida for the year 2012. Only acute care patients with a diagnosis of 
Alzheimer's disease or dementia who were hospitalized for either the dementia condition or 
because of acute urinary tract infection (UTI), pneumonia, or congestive heart failure (CHF) 
were included in this study. 
Methods: Analyses were performed using SAS v 9.3. Mean values and percentages were used 
for description. Differences between groups were tested using chi-square, t-tests, or non-
parametric statistics as appropriate. Multivariable modeling was performed using logistic 
regression. 
Results: Of the 7,308 patients in our study, 1,266 (17.3%) were readmitted within 30 days. 
However, only 1.9% of the readmitted patients received an IPC during the index admission. 
Conclusions: Inpatient palliative care consultations do positively affect the hospital 
readmissions rates for those with Alzheimer's and dementia. 
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INTRODUCTION 
We are an aging nation. The number of Baby Boomers, those born between 1946 and 
1964, are now utilizing our health care system more than ever. Many are doing so with a chronic 
illness such as dementia, or more specifically, Alzheimer's disease. The United States spends 
more per capita than any country on healthcare, yet the quality of care is often fragmented with 
very little communication and tremendous strains on family caregivers. To combat costs and 
improve patient satisfaction, hospitals have been implementing palliative care programs with 
specialists who can assist patients to navigate their disease trajectory. Unfortunately, those who 
are functionally and mentally impaired must circumnavigate among care providers who have 
vastly different objectives, workforce abilities, and quality and payment incentive models. 
Historically, palliative care was only offered to patients with a cancer diagnosis. 
However, its use has now expanded to all patients with a chronic or incurable diagnosis (Bush & 
Shahwan-Akl, 2013) including those who have been diagnosed with Alzheimer's disease or 
other dementias. An inpatient palliative care consultation (IPC), like other specialist consultation, 
is typically initiated at the request of the treating physician. IPC teams communicate their 
recommendations back to the referring physician for implementation. Additionally, palliative 
teams focus on clarifying diagnoses and treatment options, helping patients and family members 
identify goals of care, and helping them select, in conjunction with their treating physicians, the 
treatments and hospital discharge options that meet those goals (Morrison et al.. 2011 ). 
Alzheimer's disease is recognized as the leading cause of dementia, and is a chronic 
degenerative progressive disease. Along with the other dementias, disease progression in the 
moderate-to-severe stages share a common clinical pathway, being that ultimately admission to a 
specialty dementia unit, nursing home, or an acute general hospital may happen for a multitude 
49 
of reasons (Coleman, 2012). Earlier recognition of dementia patients and subsequent IPCs are 
needed to better manage predictable complications and relieve overall suffering. In particular, 
IPC services can help diagnose dementia, create an opportunity to conduct well-informed goals 
of care discussions, provide guidance in understanding prognosis, manage patients' distressful 
symptoms, provide emotional, spiritual, and social support for the patient and caregivers, and 
explore the services available at home to improve access to care upon hospital discharge (Ouchi 
et al., 2014). 
Palliative care for those with Alzheimer's disease is a growing practice trend .. Most 
immediate causes of death recorded on autopsies are pneumonia, cardiovascular events and 
pulmonary embolism. Others can include cachexia and dehydration (Aminoff & Adunsky, 2004). 
Phelan, Borson, Grothaus, Balch, and Larson (2012) studied 494 patients with dementia. Of 
those, 427 (86%) were admitted to the hospital at least once for associated conditions. Among 
participants with dementia, the average annual admission rate was 419 admissions per 1000 
persons, more than twice that of those without dementia, who averaged 200 admissions per 1000 
persons each year (crude rate ratio, 2.10; 95% CI, 1.87- 2.35;p < .001). After age and sex 
adjustment, the ratio of admission rates was 1.57 (95% CI, 1.39-1. 78; p < .001) and was 1.41 
(95% CI, 1.23-1.61;p < .001) after adjusting for additional covariates. 
Individuals with Alzheimer's disease are at an increased risk for under-treatment due to a 
lack of knowledge and respect for the disease process. It is often too complex and nuances of the 
condition are unknown to many who are responsible for treating the disease. Those with 
Alzheimer's, due to their comorbidities have greater and long-lasting burden with pain, anxiety, 
constipation, pressure sores, and restraints. Additionally the disease often causes behavioral 
changes, which prompt some health professionals to interpret as behavioral symptoms of the 
disease or the person is "just being cranky" (Mahon & Sorrell, 2008) 
so 
While there is ample research on Alzheimer's disease and growing evidence of palliative 
care being utilized in the hospital setting, little research has been conducted on how IPCs affect 
the readmission of those with this disease. Based upon these facts we hypothesized that IPCs will 
reduce hospital readmission rates for those that have Alzheimer's disease. 
METHODS 
We conducted a retrospective archival inception cohort study using hospital 
administrative claims data from the state of Florida for the calendar year of2012. The study 
design was approved by the Medical University of South Carolina Institutional Review Board as 
an exempt activity of human subjects research. 
Setting and Study Population 
We selected only acute care patients in Florida with a diagnosis of Alzheimer's disease or 
dementia who were hospitalized for either the dementia condition or because of acute urinary 
tract infection {UTI), pneumonia, or congestive heart failure (CHF). This limitation in primary 
reasons for hospital admission allowed us to examine the effect of the palliative care consult for 
a homogenous group of patients who would be expected to be at similar risk of readmission at 30 
days. 
Data 
The Healthcare Cost and Utilization Project data for 2012 for the state of Florida was 
selected because this data set allows us to link patient admissions over time to identify 
readmissions. All hospital admissions for patients with an ICD-9 code for a principal diagnosis 
of Alzheimer's disease (331.0) or dementia (290.x), or with a comorbid diagnosis code of 
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dementia or Alzheimer's disease and a principal diagnosis code for urinary tract infection (595.x, 
559.0, 595.0, 595.4), pneumonia (486.x, 481.x, 487.0, 482.83), or congestive heart failure 
(428.0) were extracted. For patients with more than one admission, the first hospital admission in 
the year for each patient was used as the index admission. Patients were linked to all subsequent 
hospital admissions for that year, and patients with an admission within 30 days of the date of 
discharge from their index admission were assigned a value of 1 on the readmission variable. 
Patients without a readmission within 30 of discharge form the index admission were assigned a 
value ofO. Variables were created from the index admission record to denote insurance 
coverage, age, sex, racial group, length of stay (LOS) and binary variables indicating discharge 
to home, nursing home hospice or other discharge destination. Patients with a code ofV66.7 
were assigned a value of 1 for inpatient palliative care consultation (IPC), patients without this 
code were set at IPC = 0. The recorded number of chronic condition codes on the index 
discharge record were used as an indicator of the patients comorbidity burden, and LOS was 
used as an indicator of severity of the index admission. 
Analysis 
Data set construction and analyses were performed using SAS v 9.3. Mean values and 
percentages were used for description of our population. We tested differences between groups 
using chi-square, t-test, or non-parametric statistics as appropriate. Multivariable modeling was 
performed using logistic regression. We controlled for differences in patient characteristics; 
including principal diagnosis and other variable that were significantly different in the univariate 
comparisons. We first fitted a complete model using all control variables. Then we removed the 




There were a number of patient characteristics that did not differ significantly between 
palliative care patients and non-palliative care patients (see Table 1 ). They were similar in their 
gender and race distributions as well as the average number of chronic conditions. However, 
those who received palliative care were significantly older (85.9 vs. 83.5 years p < .0001) than 
those who did not receive palliative care . In addition, although patients were more likely to be 
on Medicare than other forms of insurance, those without palliative care were almost entirely on 
Medicare (94. 7%) compared to those with palliative care (76.5%) and this association was 
statistically significant (p < .0001 ). 
Regarding other characteristics, it deserves noting that dementia type was also associated 
with whether a patient received or did not receive palliative care. More specifically, a slightly 
larger percentage of palliative care patients had Alzheimer's (82.1 % ) compared to non-palliative 
care patients (77 .0% p = .0173 ). We also found a different distribution of index admission 
principal diagnosis for patients who received palliative care. In particular, palliative care patients 
had more admissions for pneumonia and sepsis while non-palliative care patients were more 
often admitted for urinary tract infection or pneumonia (p < .0001 ). There were substantial 
differences in discharge destination between groups. Patient without palliative care were more 
often discharged to a nursing home (47.2%) or home (32.9%) while those with palliative care 
consults tended to be discharged to a hospice (55.2%) or other setting (28.4%) ( p <.0001 ). As 
expected, length of stay was significantly shorter for palliative care patients (5.3 vs. 6.8 days p < 
.0001) and cost was also substantially lower for palliative care patients ($8,385 vs. $9,401 p < 
.000 I) than for non-paJliative care patients. 
Of the 7308 patients in our study, 1266 (17.3%) were readmitted within 30 days (see 
Table 2). However, only 1.9% of the readmitted patients had received an IPC during the index 
admission. 
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Readmitted patients were, on average, younger (82.6 year vs. 83.8 years p < .0001) than 
patients who were not readmitted. Of those who were readmitted, 64.5% were white, which was 
significantly less than the 68.9% who were white and not readmitted (p = .0024). Notably, of 
those who were readmitted, 11.4% were black, which was significantly greater than the 9.4% 
who were black and not readmitted (p = .0313). In addition, of those who were readmitted, 
24.9% were non-black minorities compared to 21. 7% who were not readmitted. As expected, 
those were readmitted also tended to have a greater average number of chronic conditions (7.8 
vs. 7.1 p < .0001) compared to those were not readmitted. The type of insurance was also 
associated with readmission status with Medicare and Medicaid insurance coverage was more 
prevalent for those who are readmitted compared to those who are not readmitted (p = .0079). In 
summary, those who were readmitted within 30 days were less likely to have received a 
palliative care consult, were younger, more likely to be black or some other minority race, and 
have a larger average number of chronic conditions. 
There were additional differences between the readmitted patient group and those not 
readmitted within 30 days. The readmission group had a lower proportion of patients with 
Alzheimer's disease (71.9% vs. 76.2% p = .0012) than patients who were not readmitted. In 
addition, patients with an index diagnosis of congestive heart failure were much more likely to 
be readmitted than patients with other index diagnoses (p < .0001). The discharge destination for 
the index admission also affects the risk of readmission within 30 days. Patients who were 
originally discharged to home or a nursing home were more frequently readmitted than patients 
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who were discharges to hospice or other sites (p < .0001 ). Patients with a longer LOS during 
the index admission were also more likely to be readmitted than patients with a low LOS. The 
average LOS at the original admission for those were readmitted was 8.4 days compared to 6.4 
days for those who were not readmitted (p < .0001). The average cost was $11,396 vs. $8,915 (p 
< .0001). 
These descriptive statistics indicate that the characteristics of patients who were 
readmitted differ greatly, both in terms of their use of IPC and by many other factors. To clarify 
the contribution of IPC to the reduction of readmissions, we used multivariate modeling to 
examine the effect of IPC on readmission risk controlling for all the characteristics shown above. 
The results of the multivariable modeling are provided in Table 3. 
We examined the ability of having a recorded palliative care consult recorded from the 
hospital discharge summary on the risk of readmission within 30 days for our patient cohort 
using logistic regression modeling of readmissions within 30 days (readmission = 1, no 
readmission = 0). The results of the comprehensive multivariable model (Model 1) and best 
fitting model (Model 2) are provided in Table 3. The most parsimonious model is discussed 
below. 
The overall fit of the reduced model was statistically significant (p < .0001). The 
estimated odds ratio (OR) for palliative care was 0.56, indicating that patients who receive 
palliative care are about 44% less likely to be readmitted. Several variables were shown to affect 
risk of readmission in the model. Readmission risk decreased for older patients. For each 
additional year in age, the odds of being readmitted decreases by 1.3%. Hispanic patients were at 
about 22% greater risk than either Caucasian or African American patients with and OR of 1.22. 
Being discharged to a nursing home at the end of the index admission increased the risk of 
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readmission by 39% (OR= 1.39). Being discharged to hospice decreased the readmission risk by 
76% (OR = 0.24) compared to patients who were discharged to home or other settings. Patients 
who were hospitalized for CHF during the index admission had 54% greater risk of a 
readmission within 30 days than observed for patients with any other diagnoses (OR 1.54). As 
we expected, patients with a greater number of chronic conditions were at greater risk of 
readmission. For a one unit increase in the number of chronic conditions recorded, the odds of 
being readmitted increases by 4.2%. LOS for the index admission was also a predictor of 
increased risk of readmission. For a one-unit increase in the LOS, the odds of being readmitted 
increased by 2.6% (OR= 1.026). 
DISCUSSION 
This study examined readmission rates specifically for those individuals with 
Alzheimer's disease or dementia that also had an IPC. Due to recent healthcare legislations and 
penalties assessed by Medicare on hospital readmission rates, this study was necessary. Daiello, 
Gardner, Epstein-Lubow, Butterfield, and Gravenstein (2014) examined patients specifically 
readmitted with Alzheimer's and found an alarming readmission rate of 17.8%. Other 
researchers like Gaertner et al. (2013), Cheng, Dy, Fang, Chen, and Chiu (2013), Armstrong, 
Jenigiri, Hutson, Wachs, and Lambe (2013) have studied the effects ofIPCs on hospital 
readmission rates, typically for those with cancer. However, to our knowledge, this is the first 
article that brings IPCs and Alzheimer's together. While the results showing the effectiveness of 
having inpatient palliative care consultations as part of the process of care for those with 
Alzheimer's, further research needs to be completed. Specific foci for this research include 
education for hospital staff on palliative care screening, education for family members on the 
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progression of Alzheimer's disease, and better resources in the planning for transitions in care as 
a patient's needs change. 
LIMITATIONS 
Although the findings of this study were consistent with predictions based on the 
literature, there were limitations. The accuracy of coding diagnosis and documentation of the 
palliative care consultation may not be consistent across hospitals. Only one year of data was 
analyzed in one state. Perhaps to make this study more generalizable, more years and different 
states could be included in future studies. Finally, the depth of the inpatient palliative care 
consultation cannot be determined, only that a change in the process of care occurred. Rural 
hospitals may have a different palliative care program than academic teaching hospitals. Through 
this research, we are unable to determine the depth or breadth of the IPC. 
CONCLUSIONS 
These findings suggest that IPCs do affect the readmission rate for those diagnosed with 
Alzheimer's disease and other dementias. 
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Table 1: Patient Characteristics at the Index Admission 
Variable Names Patients with a Patients Statistic Total 
Palliative Care without Population 
Code Palliative Care N=7308 
N=408 N=6900 
Patient Characteristics: 
Mean a__g_e ~Dl 85.9 (8.21 83.5 (8.31 <.0001 83.6 (8.271 
Percent Female 60.5% 59.5% .8285 59.5% 
Percent White 69.6% 68.1% .5138 68.2% 
Percent Black 7.8% 9.9% .1830 9.7% 
Percent Other Race 22.6% 22.1% .8270 22.1% 
Mean (SD) Number of 7.0 (3.6) 7.2 (3.3) .2615 
Chronic conditions noted 7.2 (3.4) 
on record 
Insurance: 
Medicare 76.5% 94.7% <.0001 93.7% 
Medicaid 0.3% 1.6% 1.6% 
Commercial Insurance 9.8% 2.3% 2.7% 
Other Pqers 13.5% 1.4% 2.0% 
Dementia T_.l7P_e: 
Alzheimer's 82.1% 77.0% .0173 77.3% 
Dementia 17.9% 23.0 22.7% 
Index Admission 
Princ~al Diagnosis: 
Urin_!!!Y Tract Infection 13.7% 31.5% <.0001 30.5% 
Pneumonia 29.9% 29.0% 29.0% 
S~sis 29.4% 16.1% 16.9% 
Col!g_estive Heart Failure 9.3% 11.7% 11.5% 
Alzheimer's or Dementia 17.7% 11.7% 12.1% 
Dischar_g_e Destination: 
Dischar__g_ed to Home 4.4% 32.9% <.0001 31.3% 
Dischar__g_ed to Ho~ce 55.2% 9.3% 11.9% 
Discharged To Nursing 12.0% 47.2% 45.2% 
home 
Discharged to other 28.4% 10.6% 11.6% 
settings 
Percent with Palliative 100% 0% NA 5.58% 
Care Consult 
LOS on Index Admission 5.3_{_4.71 6.8 (7.71 <.0001 6.7 J,_7.5) 
Cost of Index Admission $8,385 $6,401 .0447 $9,344 
1$9,8091 _{_$11,3541 ($1 l,275J 
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Table 2: Characteristics of Patients by Readmission at 30 Days 
Variable Names Readmitted by 30 No Readmission Statistic 
Days Patients N=6042 
N= 1266 
Percent with Palliative Care 1.9% 6.4% <.0001 
Consult 
Patient Characteristics: 
Mean~elSDl 82.618.91 83.8 (8.11 <.0001 
Percent Female 57.7 59.9 .1348 
Percent White 64.5 68.9 .0024 
Percent Black 11.4 9.4 .0313 
Percent Other Race 24.9 21.7 .0062 
Mean (SD) Number of Chronic 7.8 (3.4) 7.1 (3.6) <.0001 
conditions noted on record 
Insurance: 
Medicare 94.2 93.6 .0079 
Medicaid 2.3 1.4 
Commercial Insurance 2.3 2.8 
OtherP~ers 1.2 2.2 
Dementia 'I)'p_e: 
Alzheimer's 71.9 76.2 .0012 
Dementia 28.1 23.8 
Index Admission Principal 
Diagnosis: 
Urin...!!!Y_ Tract Infection 30.9 30.4 <.0001 
Pneumonia 28.0 29.3 
S~sis 14.7 17.4 
Con..B_estive Heart Failure 16.0 10.6 
Alzheimer's or Dementia 10.4 12.4 
Dischar_g_e Destination: 
Dischar_g_ed to Home 33.1 30.9 <.0001 
Dischar_g_ed to Ho~ice 2.7 13.8 
Dischar..B_ed To N~in..B_ home 56.6 42.8 
Dischar..B_ed to other settin~ 7.6 12.5 
Index Admission Resources: 
LOS on Index Admission 8.4_(11.21 6.3 (6.4) <.0001 
Cost of Index Admission $11,396 ($10,584) $8,915 ($8,6531 <.0001 
61 
Table 3: Multivariable Logistic Regression Models Predictin_g_ Readmission at 30 DaIS 
Variable Names Model 1: OR Model2: OR Model 2: 
All Variables Only Significant 95%0R 
Readmitted Variables Retained Confidence 
by30 Days Readmitted by 30 Interval 
d~ 
No Palliative Care Consult 
r~rence 
Palliative Care Consult 0.697 0.557 0.362-0.858 
Patient Characteristics: 





Hi~anic 1.247 1.220 1.053-1.413 
Number of Chronic conditions 1.039 1.038 1.018-1.058 




Commercial Insurance 1.212 
Other P~rs Ref!!.rence 
Index Admission Principal 
Diagnosis: 




Con_g_estive Heart Failure 1.407 1.527 1.270-1.836 
Alzheimer's or Dementia 0.851 
Dischaqe Destination: 
Disch8I"ged to Home 1.894 
Dischar_g_ed to Ho~ce 0.379 0.235 0.164-0.338 
Dischar_g_ed To Nursin_g_ home 2.292 1.392 1.225-1.583 
Discharged to other settings 
reference 
Index Admission Resources: 
LOS on Index Admission 1.029 1.026 1.016-1.035 
